zoledronic acid has been researched along with Adrenal Cortex Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alexandre, J; Bertagna, X; Boudou-Rouquette, P; Goldwasser, F; Soubrane, O | 1 |
Alkan, A; Altundag, K; Sahin, U | 1 |
2 other study(ies) available for zoledronic acid and Adrenal Cortex Cancer
Article | Year |
---|---|
Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient.
Topics: Adrenal Cortex Neoplasms; Adult; Antineoplastic Agents; Diphosphonates; Humans; Imidazoles; Male; Neoplasm Metastasis; Radiography; Treatment Outcome; Zoledronic Acid | 2009 |
Bone morphogenetic proteins and zoledronic acid.
Topics: Adrenal Cortex Neoplasms; Bone Density Conservation Agents; Bone Morphogenetic Proteins; Diphosphonates; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Neoplasm Metastasis; Zoledronic Acid | 2009 |